http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I727152-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ce29993a01365ef39ada329db554fd0 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 |
| filingDate | 2018-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6178642237c1cb1258537b36ec8afb7b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd8b32b738a2ffc4b0be14a0c699ceb0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bb952ac7b7464cf54ae344148fd481e |
| publicationDate | 2021-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-I727152-B |
| titleOfInvention | Alkynyl heterocyclic compound, its preparation method and its application in medicine |
| abstract | The invention relates to an alkyne heterocyclic compound as an FGFR inhibitor, a preparation method thereof and its application in medicine. Specifically, the present invention relates to a compound represented by the general formula (I) and a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the compound or a pharmaceutically acceptable salt thereof, and the application of the compound or a pharmaceutically acceptable salt thereof A method for treating and/or preventing FGFR-related disorders, especially tumors, and a method for preparing the compound or a pharmaceutically acceptable salt thereof. The present invention also relates to the compound or a pharmaceutically acceptable salt thereof or a pharmaceutical composition containing the compound or a pharmaceutically acceptable salt in the preparation of a medicament for the treatment and/or prevention of FGFR-related disorders, particularly tumors the use of. Wherein, each substituent of the general formula (I) has the same definition as in the specification. |
| priorityDate | 2018-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 282.